Iris Acquisition II Corp (IRAB) Stock Analysis

AI analysis of Iris Acquisition II Corp (IRAB)

Hold

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.

Valuation Metrics

The current forward P/E ratio for Iris Acquisition II Corp (IRAB) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

Whales holding IRAB

C

Cable Car Capital LLC

+ HoldingIRAB

-4.58%

3M Return

A

Aristeia Capital, LLC

+ HoldingIRAB

-5.59%

3M Return

IRAB FAQ — answered by Alphio AI

Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It operates in the Financials sector.

Iris Acquisition II Corp (IRAB) is currently priced at $10.03, showing a 52-week high of $10.17 and a low of $9.81, indicating it is near the upper end of its range. The RSI is at 61.741, suggesting it is approaching overbought territory, which may limit short-term upside. The forward P/E ratio is currently at 0, indicating uncertainty in future earnings, while the stock has shown a 1.62% year-to-date increase. However, the net income for the last two quarters has been positive, with $1,263,575 reported in Q2 2026. The main risk is the high P/E ratio of 116.76, which may indicate overvaluation if earnings do not improve significantly. Therefore, while there are some positive indicators, the lack of consistent financial performance and high valuation metrics suggest holding rather than buying at this time.